B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment
| dc.contributor.author | Agmon-Levin, Nancy | |
| dc.contributor.author | Ignatenko, Stanislav | |
| dc.contributor.author | Gordienko, Alexander | |
| dc.contributor.author | Cortés-Hernández, Josefina | |
| dc.contributor.author | Narongroeknawin, Pongthorn | |
| dc.contributor.author | Romanowska-Próchnicka, Katarzyna | |
| dc.contributor.author | Shen, Nan | |
| dc.contributor.author | Ciferská, Hana | |
| dc.contributor.author | Kodera, Masanari | |
| dc.contributor.author | Cheng-Chung, Wei J. | |
| dc.contributor.author | Leszczyński, Piotr | |
| dc.contributor.author | Lan, Joung-Liang | |
| dc.contributor.author | Mysler, Eduardo | |
| dc.contributor.author | Wojciechowski, Rafal | |
| dc.contributor.author | Tarr, Tünde | |
| dc.contributor.author | Vishneva, Elena | |
| dc.contributor.author | Chen, Yi-Hsing | |
| dc.contributor.author | Kaneko, Yuko | |
| dc.contributor.author | Finzel, Stephanie | |
| dc.contributor.author | Hoi, Alberta | |
| dc.contributor.author | Okada, Masato | |
| dc.contributor.author | Koolvisoot, Ajchara | |
| dc.contributor.author | Lee, Shin-Seok | |
| dc.contributor.author | Lie, Dai | |
| dc.contributor.author | Kaneko, Hiroshi | |
| dc.contributor.author | Rojkovich, Bernadette | |
| dc.contributor.author | Sun, Lingyun | |
| dc.contributor.author | Zotkin, Eugeny | |
| dc.contributor.author | Viallard, Jean-Francoise | |
| dc.contributor.author | López, Berta Paula Magallares | |
| dc.contributor.author | Ghanshani, Swati Aashish | |
| dc.contributor.author | Lau, Carol | |
| dc.contributor.author | Avrameas, Alexandre | |
| dc.contributor.author | Sips, Carole | |
| dc.contributor.author | Oliver, Stephen John | |
| dc.date.accessioned | 2026-03-09T07:19:56Z | |
| dc.date.available | 2026-03-09T07:19:56Z | |
| dc.date.issued | 2026 | |
| dc.date.oa | 2026-03-20 | |
| dc.date.pasync | 2026-03-20T00:10:45Z | |
| dc.date.updated | 2026-03-09T07:19:56Z | |
| dc.description.corrector | bkata | |
| dc.identifier.citation | Annals Of The Rheumatic Diseases. -85 : 3 (2026), p. 476-488. -Ann. Rheum. Dis. - 0003-4967 | |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.ard.2025.11.015 | |
| dc.identifier.issn | 0003-4967 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM136071 | |
| dc.identifier.scopus | 105025241510 | |
| dc.identifier.uri | https://hdl.handle.net/2437/405415 | |
| dc.identifier.url | https://linkinghub.elsevier.com/retrieve/pii/S0003496725045479 | |
| dc.identifier.wos | 001708224300001 | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.owner | szerző | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | B cell depletion and BAFF receptor blockade with ianalumab (VAY736) for the treatment of moderate-to-severe systemic lupus erythematosus: a phase 2 randomised, double-blind, placebo-controlled trial with subsequent open-label treatment | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_0_1-s2.0-S0003496725045479-main.pdf
- Méret:
- 817.71 KB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Kiadó változat